This product is not clubbable with other items in cart. Please remove this or other items to proceed further.
No Items In Cart
The Standing Committee of the National People’s Congress in China passed the revised Drug Administration Law (Revised Law) on 26-Aug-19. Effective 1-Dec-19, it is the first overhaul since 2001.The Revised Law addresses the major issues in the pharmaceutical industry, demonstrating the government’s efforts in strengthening supervision to ensure drug safety.
The main provisions are:
The Revised Law is more aligned with international standards. The National Medical Products Administration (NMPA) is working on the development and revision of necessary regulatory documents and technical guidelines to further support the implementation of the Revised Law.
West is vigilant of the ever-changing regulatory landscape in order to support customers with the information, products, and services needed in order to comply. For more information, contact an Account Manager or Technical Customer Support (TCS) representative, or visit the West Knowledge Center.
Take an in-depth look at the science behind containment & delivery of injectable medicines in the West Knowledge Center.